Antibiotics — Editors

Journal Contact

Antibiotics Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Prof. Dr. Christopher C. Butler
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK
Interests: antibiotic use; common infections; antibiotic resistance; clinical trials; observational studies; qualitative research

Prof. Dr. Leonard Amaral
Travel Medicine, Center for Malaria and Tropical Disease (CMDT), Institute of Hygiene & Tropical Medicine, Universidade Nova de Lisboa, Rua Junqueira 100, 1349-008 Lisbon, Portugal
Interests: antibiotic resistance; multi-drug resistance; bacterial infections; efflux pumps; reversal of resistance; MDR/XDR Tb; therapy; molecular genetics; molecular biology; drug discovery
Contribution: Special Issue: Efflux Pumps of Multi-Drug Resistant Pathogenic Bacteria: Their Genetic Regulation, Molecular Biology and Possible Control with Newly Designed Agents
Prof. Dr. Dan I. Andersson
Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala Biomedicinska Centrum BMC, Husarg. 3, 751 23 Uppsala, Sweden
Interests: antibiotic resistance mechanisms; antibiotic action; bacterial genetics; molecular and experimental evolution
Contribution: Special Issue: Antibiotic Resistance
Prof. Dr. Gregory L. Challis
Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK
Interests: antibiotic biosynthesis; natural product discovery; biosynthetic engineering
Prof. Dr. Patrice Courvalin
Institut Pasteur, Antibacterial Agents Unit, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France
Interests: antibiotic resistance; genetics; biochemistry; gene transfer; human pathogens; infectious diseases
Dr. Andrei L. Gartel
Department of Medicine, 840 S Wood St, Room 1041, University of Illinois at Chicago, Chicago, IL 60612, USA
Interests: thiazole antibiotics as anticancer drugs; antibiotics against cancer; antibiotics as proteasome inhibitors; antibiotic mechanisms of action in mammalian cells
Prof. Dr. Christian Girard
Unité de Technologies Chimiques & Biologiques pour la Santé, Equipe SEISAD - Synthèse Electrochimie, Imagerie et Systèmes Analytiques pour le Diagnostique, UMR 8258 CNRS / U 1022 INSERM, Ecole Nationale Supérieure de Chimie de Paris 11, rue P. & M. Curie, 75231 Paris cedex 05, France
Contribution: In other journals:
Special Issue: Click Chemistry
Prof. Dr. Elizabeth Harry
The ithree institute, University of Technology Sydney (UTS), P.O. Box 123, Broadway, NSW 2007, Australia
Interests: bacterial cell division; medicinal honey; natural product antibacterials; mechanisms of action of antibiotics; drug discovery (including natural products, antibiotic resistance)
Contribution: Special Issue: Discover New Antibiotics
Prof. Dr. Thomas Hermann
Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, MC 0358, La Jolla, CA 92093-0358, USA
Interests: translation and ribosome as antibiotic targets; RNA targets; new classes of antibiotics; antibiotic mechanism of action; mechanisms of antibiotic resistance; medicinal chemistry; X-ray crystallography
Prof. Dr. Victoria Korolik
Institute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia
Interests: molecular pathogenesis; molecular mimicry; host-microbe interactions; chemotaxis; novel antimicrobials and biofilms
Dr. Kenny Kung
Division of Family Medicine, 4/F, The Jockey Club School of Public Health and Primary Care, Prince of Wales Hospital, Shatin, NT, Hong Kong
Interests: respiratory tract infections; antibiotic use; doctor training; health services improvement
Contribution: Special Issue: Antibiotics and Respiratory Tract Infections
Dr. Morten Lindbæk
Avdeling for allmennmedisin, Postboks 1130, Blindern 0318, Oslo, Norway
Prof. Dr. Jeffrey Lipman
Discipline of Anaesthesiology and Critical Care, The University of Queensland School of Medicine, Department of Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Herston, QLD 4029, Australia
Interests: antibiotic administration (particularly pharmacokinetics); pharmacodynamics; clinical trials
Prof. Dr. Alexander Mankin
University of Illinois at Chicago, Molecular Biology Research Building, 900 South Ashland (M/C 870), Chicago, IL 60607-7173, USA
Interests: molecular mechanisms of protein synthesis; mechanisms of antibiotic action; mechanisms of antibiotic resistance
Prof. Dr. Shahriar Mobashery
Department of Chemistry and Biochemistry, Nieuwland Science Center, University of Notre Dame, Notre Dame, IN 46556, USA
Interests: new classes of antibiotics; antibiotic mechanism of action; mechanisms of antibiotic resistance
Dr. David P. Nicolau
Center for Anti-Infective Research & Development Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA
Interests: pharmacokinetic; pharmacodynamics; outcomes; economics
Dr. Boris Nikonenko
Sequella, Inc., 9610 Medical Center Drive, Suite 200, Rockville, Maryland, 20850, USA
Interests: inbred mouse strains; experimental tuberculosis (TB), therapy of TB and non-TB infections in mouse model; latent TB and relapse of TB infection after therapy termination in mouse model
Prof. Dr. Evgeny Nudler
Julie Wilson Anderson Professor; Investigator, Howard Hughes Medical Institute; Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, The Alexandria Center of Life Sciences, 450 E 29th Street, Room 303, New York, NY 10016, USA
Interests: bacterial stress response; mechanisms of antibiotic resistance; molecular mechanisms of bacterial transcription
Dr. Luísa Peixe
University of Porto, Faculty of Pharmacy, Laboratory of Microbiology, Rua Jorge Viterbo Ferreira nº 228, 4050-313 Porto, Portugal
Interests: antimicrobials mechanism of action; mechanisms of antimicrobials resistance; new classes of antibiotics; anti-biofilm activity
Prof. Dr. Angelina Pena
Group of Health Surveillance, Center of Pharmaceutical Studies Faculty of Pharmacy, University of Coimbra, Health Sciences Campus, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
Interests: antibiotic use (including on animals and in agriculture); new methods for assaying and evaluating antibiotics; observational studies; qualitative and quantitative research; food and environmental residues
Contribution: Special Issue: The Environmental Footprint of Antibiotics
Dr. Floyd Eric Romesberg
Department of Chemistry, The Scripps Research Institute, CB262R, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA
Interests: mechanisms of antibiotic resistance: antibiotic mechanisms of action; new classes of antibiotics
Prof. Dr. Gian Maria Rossolini
1. Full Professor of Microbiology and Clinical Microbiology, Department of Medical Biotechnologies, University of Siena, Policlinico “Santa Maria alle Scotte”, Viale Bracci 1, 53100 Siena, Italy
2. Full Professor of Microbiology and Clinical Microbiology, Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy
3. Director of Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy
Interests: microbial drug resistance; beta-lactams; beta-lactamases; carbapenemases; molecular epidemiology; Gram-negative pathogens; new antimicrobials; clinical outcome
Dr. William M. Shafer
Department of Microbiology and Immunology, School of Medicine, Emory University, Rollins Research Center, Atlanta, GA, USA
Interests: antimicrobial peptides; evolution; molecular biology; regulation; synthesis; structure-function; host defense; bacterial diseases; immune-modulation; inflammation
Contribution: Special Issue: Antimicrobial Peptides
Prof. Dr. Gary A. Strobel
Department of Plant Sciences, Montana State University, Bozeman, MT 59717, USA
Interests: biology, biochemistry and utility of endophytic microbes
Prof. Dr. Françoise Van Bambeke
Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain, Avenue Mounier 73 B1.73.05, 1200 Brussels, Belgium
Interests: new antibiotics; pharmacokinetics and pharmacodynamics; intracellular infection; efflux transporters
Contribution: In other journals:
Special Issue: Advances in Medicinal Chemistry of Antibiotics
Prof. Dr. Ying Zhang
Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe Street, Baltimore, MD 21205, USA
Interests: mechanisms of persister drug pyrazinamide (PZA) action and resistance in M. tuberculosis; mechanisms of bacterial persistence and L-forms; mycobacterial pathogenesis; development of novel drugs and vaccines targeting persister bacteria; development of novel diagnostic tools for improved detection of TB and drug-resistant TB; Cancer stem cell mechanisms and drugs
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert